Achilles Corporation
Financial Results Briefing Materials for the Fiscal Year Ending March 2026
growth-focused structural reform and prioritization underway. Growth businesses are driving performance, with actual results exceeding the raised forecast; for the fiscal year ending March 2027, a prudent plan is formulated while incorporating uncertainty. Medical-grade films and semiconductor-related materials are driving growth, and restructuring, including the termination of domestic production in the footwear business, is underway.
Key Figures
- Sales 81.8 billion yen (FY2025 results) → FY2026 results unknown → 82.5 billion yen (FY2027 forecast)
- Operating profit 2.9 billion yen (FY2025) → FY2026 2.2 billion yen (raised forecast) → FY2027 3,000 million yen forecast
- Dividend per share (DPS) 50 yen assumed (FY2027 plan)
AI要約
Section heading
At the earnings briefing, emphasis is placed on restoring profitability through structural reforms and growth strategies. Progress on the medium-term plan, particularly focusing on high-value-added areas and global expansion, contributed to improved performance. Structural reforms such as the domestic production termination in the footwear business progressed, reporting an upper-than-forecast result for FY2026 (year ending March 2026). For FY2027 (year ending March 2027), a cautious plan is being drafted by incorporating geopolitical risks and other uncertainties.
Section 2 heading
By segment, the first business unit saw a revenue increase in high-performance films and semiconductor-related materials, the second business unit maintained steady demand for insulation materials and building materials, and the footwear BU experienced a decline in sales. In the medium-term plan toward Vision 2030, the company will pursue the three corporate strategies of selection and concentration and global strategy. On the financial side, cash flow stability and shareholder returns are prioritized, and proactive investment and investments in human capital will continue.
売上高推移
営業利益推移
セグメント別売上高構成
粗利率・利益率推移
Achilles Co., Ltd.
Company overview · Stock price · Financial data · All IR
